Berke Demiriz

Berke Demiriz

Auto-generated profile, based on publicly available information

Berke Demiriz

Department of Urology, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in Trakya University Journal of Natural Sciences
Verified
Journal Article
Open access
PDF file
ÖSÖzge Sezin Somuncu
Özge Sezin Somuncu
BDBerke Demi̇rİz
Berke Demi̇rİz
ITİrEm Türkmen
İrEm Türkmen
SSSalih Somuncu
Salih Somuncu
BABerna Aksoy
Berna Aksoy
Psoriasis is a multifactorial chronic inflammatory disorder resulting by the interplay of genetics, the immune system and the environment. It is characterized by the hyperproliferation of epithelial cells, generating red, itchy psoriatic plaques which have no cure but have great negative impact in patients’ life. Although corticosteroids or vitamin D analogs might help recovery to some extent, there is yet no total cure for the disease. In this study, we sought to generate three-dimensional (3D) stress-related psoriatic skin spheroids with the screening of the potential efficacy of a β2-adrenergic receptor agonist, salbutamol. 3D Culture spheroids with human dermal fibroblasts (HDF), human epithelial keratinocytes (HEK) and human monocytic cell line (THP-1) were generated as a representative model of skin and the protocol of stress-related modelling was conducted. The efficacy of the drug salbutamol was evaluated by the changes in mRNA and protein expression levels of selected genes, as well as by several metabolic assays. We developed a method for culturing spherical organoid models of psoriasis in vitro. We tested the potential theurapetic effects of salbutamol on psoriasis spheroids. Spheroids treated with salbutamol indicated the effictiveness of the treatment. 3D spheroid system was found partially efficient for mimicking the physiological features of psoriasis in vitro. This present work may be a starting point for future investigation as it is the first to generate a stress-related psoriatic model and first to try a β2 agonist as a potential treatment option. Considering the effects and suitability of topical application of salbutamol, its efficacy should not be underestimated and should be investigated further for translating this knowledge into clinics.

27 July 2026 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
RURamazan UĞUR
Ramazan UĞUR
BDBerke Demiriz
Berke Demiriz
ONOnuralp Nişli
Onuralp Nişli
EKEmin Taha Keskin
Emin Taha Keskin
SŞSüleyman Şahin
Süleyman Şahin
HCHalil Lutfi Canat
Halil Lutfi Canat

6 August 2025 in Urolithiasis
Verified
Journal Article
Open access
PDF file
AEAkif Erbin
Akif Erbin
CTCemal Topal
Cemal Topal
BDBerke Demiriz
Berke Demiriz
KTKemal Topaloglu
Kemal Topaloglu

1 August 2026 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
RURamazan UĞUR
Ramazan UĞUR
BDBerke Demiriz
Berke Demiriz
ONOnuralp Nişli
Onuralp Nişli
EKEmin Taha Keskin
Emin Taha Keskin
SŞSüleyman Şahin
Süleyman Şahin
HCHalil Lutfi Canat
Halil Lutfi Canat